Chatbot Localization for Life Sciences

Respond to queries faster, more accurately, in any language, and with specialized and customized informative responses.

Get in Touch
Person holding up a chatbot icon

Engage your key stakeholders with conversational AI

Life sciences organizations are increasingly looking for ways to better leverage data to improve the consumer experience. With the majority of the global population conducting research online about products and services they are interested in, now more than ever, chatbots represent a unique opportunity to effectively engage key stakeholder requests with informative and fast responses.

TransPerfect Life Sciences has the experience and expertise to help you reach key stakeholders around the world through language AI support for training conversational AI technology. Our services include generating datasets, annotating unstructured language data to train conversational technology, and, of course, chatbot localization.

Thank

Respond to patient and HCP multilingual queries faster without sacrificing quality

Our expert linguists are experienced in localizing life sciences chatbots to better reach and engage patients, HCPs, and other stakeholders globally in more than 200 languages.

Chatbot Localization for Catalia Health

Read The Case Study ›

Simplify Multilingual Conversational AI

Whether it’s creating a virtual agent to help train employees, enhancing an existing virtual agent to answer consumer queries, or localizing a chatbot to engage a new audience, TransPerfect’s AI division, DataForce, can support your development of specialized chatbots trained in clinical and medical terminology that can easily integrate with your systems. We have a simple recipe for success:

  • Icon Signed

Design:

Prototypes and designs are created and tested, and feedback is collected to implement changes.

  • Icon AI Integrations

Build:

Conversational AI models are developed and integrated with existing systems before defining business logic, including prompt localization.

  • Icon Computer with Charts

Manage:

Chatbots are deployed, modified, and tested across all voice and chat channels to ensure optimal user experience.

  • Icon Lightbulb

Enhance:

Once deployed, quality analysis is conducted to improve accuracy and engagement with automated testing.

Trusted by Life Sciences Organizations Big and Small

Join TransPerfect's community of over 1,000 life sciences organizations, including pharma, biotech, CROs, IRBs, and agencies.

20230124-lifesciences-resize-v3_0022_400x160px-hologic_logo.png
untitled_design_4.png
20230124-lifesciences-resize-v3_0016_400x160px-bayer_logo.png
20230124-lifesciences-resize-v3_0015_400x160px-merck_logo.png

Let’s Chat About Your Chatbot Localization Strategy.

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

News and Thought Leadership

Our industry experts have in-depth understanding of the challenges, requirements, and goals for medical affairs teams in reaching global audiences.

Is AI Ready to Transform COA Development?

Blog

AI is reshaping clinical development, but its greatest value may lie not in replacing human expertise, but rather in augmenting it. Across the drug development pipeline, AI is helping teams analyze vast datasets faster, identify promising compounds earlier, and uncover patterns that may have been missed through conventional methods alone. At the same time, not every part of clinical development is equally ready for AI-driven automation. In patient-facing areas such as ...

Is AI Ready to Transform COA Development?
Webinar

AI in Medical Information: Challenges, Opportunities, and the Path to Compliant Content at Scale

Medical information teams are being asked to do more with less; faster turnaround, broader content demands, and zero tolerance for inaccuracy. AI offers a way forward, but adoption comes with real challenges: how do you validate accuracy, integrate literature review, and build ...
Webinar

Xtalks | Improve Recruitment Outcomes Through More Diverse Clinical Trials

Since the advent of artificial intelligence (AI), medical device manufacturers have been early adopters for product enhancements. Now, manufacturers are evaluating their regulated content and other production processes for suitable applications of AI and automation technology. ...
Blog

Potential Impact of the EU Biotech Act Proposal on Clinical Trial Activities

The European Commission’s proposed Biotech Act introduces changes that could reshape how clinical trials are approved and managed across the EU. While the broader package spans multiple areas of the health ecosystem, proposed updates to the EU Clinical Trial Regulation (EU...
Blog

5 Common eCOA Migration Issues

With so many clinical trials now using COAs on electronic platforms, the practice of “migration” (transferring and adapting COAs for electronic use) has become more common than ever. Without careful implementation, one minor deviation can compound across many languages,...
Checklist

A Checklist for eCOA Solution Deployment: Best Practices and Considerations

Selecting and deploying a new eCOA solution involves many important factors - from determining the capabilities of the Language Service Provider (LSP) to identifying the technology used for each COA migration - and it’s impossible not to worry about missing a key detail in the ...
Success Stories

Fortune 500 Pharma Company Meets Critical Deadlines with TransPerfect Life Sciences’ COA Solutions

This spotlight reviews the challenges faced by a Fortune 500 pharmaceutical company in implementing Clinical Outcome Assessments (COAs) to measure the impact of their products on patients. It discusses the need for accurate and culturally appropriate translations of COAs for ...